News
-
-
-
COMMUNIQUÉ DE PRESSE
Wellgistics Health Inc. Signs $105,000,000 Letter of Intent to Evaluate Potential Acquisition of Neuritek Therapeutics, Inc. which is Pioneering Innovative Therapies for Neurological and Psychiatric Disorders
Wellgistics Health, Inc. announces non-binding Letter of Intent to acquire Neuritek Therapeutics, a neuroscience-focused research organization, enhancing its healthcare platform -
-
-
COMMUNIQUÉ DE PRESSE
Wellgistics Health Announces Launch of Diabetes Drug Brenzavvy(R) to Wellgistics Pharmacy Network
Wellgistics Health launches Brenzavvy to target the $16 billion SGLT-2 inhibitor market, focusing on patient education and reduced costs. Proprietary EinsteinRx AI platform supports broader market access and enhanced care experience for diabetics -
-
-
COMMUNIQUÉ DE PRESSE
Wellgistics Health Announces that it will Distribute a Dream Bowl 2026 Meme Coin to Wellgistics Health Stockholders
Wellgistics Health, Inc. sets record date for Dream Bowl 2026 Meme Coin distribution to shareholders, to optimize prescription medicines journey using blockchain technology -
